Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization to improve functional outcome after spinal cord injury in the rat

L. Urdziková, K. Likavčanová-Mašínová, V. Vaněček, J. Růžička, J. Sedý, E. Syková, P. Jendelová

. 2011 ; 13 (9) : 1090-1104. [pub] 20110504

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12022210

BACKGROUND AIMS: The effect of granulocyte-colony-stimulating factor (G-CSF) and/or the cytokine fms-like thyrosin kinase 3 (Flt3) ligand on functional outcome and tissue regeneration was studied in a rat model of spinal cord injury (SCI). METHODS: Rats with a balloon-induced compression lesion were injected with G-CSF and/or Flt3 ligand to mobilize bone marrow cells. Behavioral tests (Basso-Beattie-Bresnahan and plantar test), blood counts, morphometric evaluation of the white and gray matter, and histology were performed 5 weeks after SCI. RESULTS: The mobilization of bone marrow cells by G-CSF, Flt3 ligand and their combination improved the motor and sensory performance of rats with SCI, reduced glial scarring, increased axonal sprouting and spared white and gray matter in the lesion. The best results were obtained with a combination of G-CSF and Flt3. G-CSF alone or in combination with Flt3 ligand significantly increased the number of white blood cells, but not red blood cells or hemoglobin content, during and after the time-course of bone marrow stimulation. The combination of factors led to infiltration of the lesion by CD11b(+) cells. CONCLUSIONS: The observed improvement in behavioral and morphologic parameters and tissue regeneration in animals with SCI treated with a combination of both factors could be associated with a prolonged time-course of mobilization of bone marrow cells. The intravenous administration of G-CSF and/or Flt3 ligand represents a safe and effective treatment modality for SCI.

000      
00000naa a2200000 a 4500
001      
bmc12022210
003      
CZ-PrNML
005      
20160308103242.0
007      
ta
008      
120806s2011 xxk f 000 0#eng||
009      
AR
024    7_
$a 10.3109/14653249.2011.575355 $2 doi
035    __
$a (PubMed)21539498
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Urdzíková, Lucia $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic $7 xx0136406
245    10
$a Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization to improve functional outcome after spinal cord injury in the rat / $c L. Urdziková, K. Likavčanová-Mašínová, V. Vaněček, J. Růžička, J. Sedý, E. Syková, P. Jendelová
520    9_
$a BACKGROUND AIMS: The effect of granulocyte-colony-stimulating factor (G-CSF) and/or the cytokine fms-like thyrosin kinase 3 (Flt3) ligand on functional outcome and tissue regeneration was studied in a rat model of spinal cord injury (SCI). METHODS: Rats with a balloon-induced compression lesion were injected with G-CSF and/or Flt3 ligand to mobilize bone marrow cells. Behavioral tests (Basso-Beattie-Bresnahan and plantar test), blood counts, morphometric evaluation of the white and gray matter, and histology were performed 5 weeks after SCI. RESULTS: The mobilization of bone marrow cells by G-CSF, Flt3 ligand and their combination improved the motor and sensory performance of rats with SCI, reduced glial scarring, increased axonal sprouting and spared white and gray matter in the lesion. The best results were obtained with a combination of G-CSF and Flt3. G-CSF alone or in combination with Flt3 ligand significantly increased the number of white blood cells, but not red blood cells or hemoglobin content, during and after the time-course of bone marrow stimulation. The combination of factors led to infiltration of the lesion by CD11b(+) cells. CONCLUSIONS: The observed improvement in behavioral and morphologic parameters and tissue regeneration in animals with SCI treated with a combination of both factors could be associated with a prolonged time-course of mobilization of bone marrow cells. The intravenous administration of G-CSF and/or Flt3 ligand represents a safe and effective treatment modality for SCI.
650    _2
$a zvířata $7 D000818
650    _2
$a chování $x účinky léků $7 D001519
650    _2
$a buňky kostní dřeně $x účinky léků $x metabolismus $x patologie $7 D001854
650    _2
$a mozek $x účinky léků $x metabolismus $x patologie $7 D001921
650    _2
$a buňky - růstové procesy $x účinky léků $7 D048708
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a kultivované buňky $7 D002478
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a synergismus léků $7 D004357
650    _2
$a faktor stimulující kolonie granulocytů $x aplikace a dávkování $x škodlivé účinky $7 D016179
650    _2
$a řízená tkáňová regenerace $7 D048091
650    _2
$a mobilizace hematopoetických kmenových buněk $7 D019650
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové proteiny $x aplikace a dávkování $x škodlivé účinky $7 D008565
650    _2
$a pohybová aktivita $x účinky léků $7 D009043
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a čití, cítění $x účinky léků $7 D012677
650    _2
$a poranění míchy $x patologie $x patofyziologie $x chirurgie $x terapie $7 D013119
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Likavčanová-Mašínová, Katarína $7 _AN049556
700    1_
$a Vaněček, Václav $7 xx0246192
700    1_
$a Růžička, Jiří
700    1_
$a Šedý, Jiří, $d 1980- $7 mzk2007411473
700    1_
$a Syková, Eva, $d 1944- $7 jn20000710633
700    1_
$a Jendelová, Pavla, $d 1965- $7 xx0068971
773    0_
$w MED00010464 $t Cytotherapy $x 1477-2566 $g Roč. 13, č. 9 (2011), s. 1090-1104
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21539498 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120806 $b ABA008
991    __
$a 20160308103257 $b ABA008
999    __
$a ok $b bmc $g 944123 $s 779507
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 13 $c 9 $d 1090-1104 $e 20110504 $i 1477-2566 $m Cytotherapy $n Cytotherapy $x MED00010464
LZP    __
$b NLK111 $a Pubmed-20120806/12/01

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...